Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model

BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterized by recurrent epistaxis, mucocutaneous telangiectasia, and arteriovenous malformations. The efficacy of traditional treatments for HHT is very limited. The aim of this study was to investigate the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Hong-Ling, Yi, Yi-Fang, Zhou, Shun-Ke, Xie, Si-Si, Zhang, Guang-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795244/
https://www.ncbi.nlm.nih.gov/pubmed/26608985
http://dx.doi.org/10.4103/0366-6999.169068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795244/
https://www.ncbi.nlm.nih.gov/pubmed/26608985
http://dx.doi.org/10.4103/0366-6999.169068

Ejemplares similares